Product Information

APREPITANT 80 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $76.8519 per EA under NDC 68462058458. Its NADAC has been published 192 times since Jul 21, 2021.

FDA first approved this application on Oct 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

APREPITANT 80 MG CAPSULE

Aprepitant
$76.8519per EA

Strength

80 mg/1

NDC

68462058458

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA207777

FDA Approved

10/12/2017

TE Code

AB

On Market Since

10/12/2017

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price Statistics

The NADAC for APREPITANT 80 MG CAPSULE has been published 192 times since Jul 21, 2021, and over the history we have for it it has declined 40.9%. The table below summarizes its recorded NADAC range and movement.

Current price$76.8519 per EA
All-time high$130.0157 (Jul 13, 2022)
All-time low$63.4544 (May 20, 2026)
52-week high$90.8605
52-week low$63.4544
Median price$85.2340
Average price$93.5207
Largest weekly change-41.5% (Dec 20, 2023)
Weeks tracked192
Tracking sinceJul 21, 2021

Price History

1W

+8.2%

1M

+8.2%

3M

+21.1%

6M

+14.9%

1Y

-13.8%

3Y

-40.9%

5Y

-40.9%

All

-40.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of APREPITANT 80 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 80 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $76.8519 per EA (NDC 68462058458), effective Aug 19, 2026.

How has the price of APREPITANT 80 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for APREPITANT 80 MG CAPSULE has declined 40.9%. It has been tracked across 192 weekly CMS publications since Jul 21, 2021.

What are the highest and lowest recorded NADAC prices for APREPITANT 80 MG CAPSULE?

Since Jul 21, 2021, the NADAC for APREPITANT 80 MG CAPSULE has ranged from a low of $63.4544 (May 20, 2026) to a high of $130.0157 (Jul 13, 2022), with a median of $85.2340 per EA.

Are there cheaper alternatives to APREPITANT 80 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as APREPITANT 80 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures APREPITANT 80 MG CAPSULE?

APREPITANT 80 MG CAPSULE (NDC 68462058458) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.